[ad_1]
Requested for emergency use of Corona 19 vaccine to the FDA, Pfizer is the first
When the vaccine is approved, vaccination begins in December.
Pfizer. (Photo = AP = Yonhap News)
Pfizer and Bioentech, a leader in the development of vaccines for the new coronavirus infection (Corona 19), have applied for emergency use of the vaccine in the United States and the United Kingdom.
On the 20th (local time), according to Reuters and Associated Press, Pfizer requested an emergency use of the vaccine from the US Food and Drug Administration (FDA). Pfizer is the first to request emergency use of Corona 19 vaccine from the FDA.
Pfizer said it expects the FDA to approve the emergency use by the middle of next month and, if approved, it will begin distribution almost immediately.
Pfizer plans to prepare 50 million doses of vaccine this year, which can be administered by 25 million people.
The FDA has tentatively decided to hold an advisory committee meeting next month 8-10 to discuss approval of the vaccine, Reuters said.
In addition, the UK government has entered the approval process for the Corona 19 vaccine developed by Pfizer and Bioentech.
According to the Reuters news agency on the 20th, British Health Minister Matt Hancock revealed this fact through a press conference in response to Corona 19.
“The first step towards a vaccine license in the UK is for the government to make a formal request for conformity assessment to the independent regulatory body, the Pharmaceutical and Healthcare Products Regulatory Authority (MHRA),” Hancock said. I delivered it “.
Minister Hancock said that if the vaccine is approved, vaccination will begin in December and continue on a large scale next year.
Pfizer and Bioentech announced that the co-developed COVID-19 vaccine had a 95% infection prevention effect in a phase 3 clinical trial and no major safety concerns were found.
This is an upward revision of the average ad of 90%. In particular, Pfizer revealed that the prevention effect has been shown to be excellent for people over 65 who are vulnerable to Corona 19.
Hankyung.com Newsroom [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
